Interventional pathway in the management of refractory post cholecystectomy pain (PCP) syndrome: a 6-year prospective audit in 60 patients

被引:2
作者
Lee, Hayun [3 ]
Kukreja, Yuvraj [4 ]
Niraj, G. [1 ,2 ]
机构
[1] Univ Leicester, Univ Hosp Leicester NHS Trust, Dept Pain Med, Clin Res Unit Pain Med, Gwendolen Rd, Leicester LE5 4PW, England
[2] Univ Leicester, Univ Hosp Leicester NHS Trust, Gwendolen Rd, Leicester LE5 4PW, England
[3] Univ Hosp Leicester NHS Trust, Dept Pain Med, Leicester, England
[4] Univ Hosp Leicester NHS Trust, Leicester, England
关键词
abdominal myofascial pain syndrome; abdominal pain; ACNES; post cholecystectomy syndrome; pulsed radiofrequency treatment; VISCERAL PAIN; ANALGESIA; OUTCOMES; TRIAL;
D O I
10.1515/sjpain-2022-0090
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Post cholecystectomy pain syndrome can affect over a third of patients undergoing laparoscopic cholecystectomy. Acute exacerbations can result in recurrent emergency admission with excessive healthcare utilization. Standard surgical management appears to focus on visceral aetiology. Abdominal myofascial pain syndrome is a poorly recognised somatic pathology that can cause refractory pain in this cohort. It develops as a result of trigger points in the abdominal musculature. The report describes the pathophysiology and a novel interventional pathway in the management of post cholecystectomy pain secondary to abdominal myofascial pain syndrome.Methods: The prospective longitudinal audit was performed at a tertiary pain medicine clinic in a university teaching hospital. Over a six-year period, adult patients with refractory abdominal pain following laparoscopic cholecystectomy were included in a structured interventional management pathway. The pathway included two interventions. Intervention I was a combination of abdominal plane blocks and epigastric port site trigger injection with steroids. Patients who failed to report durable relief (> 50% pain relief at 12 weeks) were offered pulsed radiofrequency treatment to the abdominal planes (Intervention II). Outcomes included patient satisfaction, change in opioid consumption and impact on emergency visits.Results: Sixty patients who failed to respond to standard management were offered the pathway. Four patients refused due to needle phobia. Fifty-six patients received Intervention I. Failure rate was 14% (8/56). Forty-eight patients (48/56, 86%) reported significant benefit at 12 weeks while 38 patients reported durable relief at 24 weeks (38/56, 68%). Nine patients received Intervention II and all (100%) reported durable relief. Emergency admissions and opioid consumption were reduced.Conclusions: Abdominal myofascial pain syndrome is a poorly recognised cause of post cholecystectomy pain. The novel interventional management pathway could be an effective solution in patients who fail to benefit from standard management.
引用
收藏
页码:712 / 719
页数:8
相关论文
共 35 条
  • [1] The Brief Pain Inventory and Its "Pain At Its Worst in the Last 24 Hours" Item: Clinical Trial Endpoint Considerations
    Atkinson, Thomas M.
    Mendoza, Tito R.
    Sit, Laura
    Passik, Steven
    Scher, Howard I.
    Cleeland, Charles
    Basch, Ethan
    [J]. PAIN MEDICINE, 2010, 11 (03) : 337 - 346
  • [2] Sphincter of oddi dysfunction
    Baillie J.
    [J]. Current Gastroenterology Reports, 2010, 12 (2) : 130 - 134
  • [3] How to manage postcholecystectomy abdominal pain
    Bekkali, Noor L. H.
    Oppong, Kofi W.
    [J]. FRONTLINE GASTROENTEROLOGY, 2021, 12 (02) : 145 - 150
  • [4] Bodvall B, 1973, Clin Gastroenterol, V2, P103
  • [5] Chronic Abdominal Wall Pain: Clinical Features, Health Care Costs, and Long-term Outcome
    Costanza, Christopher D.
    Longstreth, George F.
    Liu, Amy L.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (05) : 395 - 399
  • [6] A critical evaluation of Quintner et al: Missing the point
    Dommerholt, Jan
    Gerwin, Robert D.
    [J]. JOURNAL OF BODYWORK AND MOVEMENT THERAPIES, 2015, 19 (02) : 193 - 204
  • [7] Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
    Dworkin, Robert H.
    Turk, Dennis C.
    Wyrwich, Kathleen W.
    Beaton, Dorcas
    Cleeland, Charles S.
    Farrar, John T.
    Haythornthwaite, Jennifer A.
    Jensen, Mark P.
    Kerns, Robert D.
    Ader, Deborah N.
    Brandenburg, Nancy
    Burke, Laurie B.
    Cella, David
    Chandler, Julie
    Cowan, Penny
    Dimitrova, Rozalina
    Dionne, Raymond
    Hertz, Sharon
    Jadad, Alejandro R.
    Katz, Nathaniel P.
    Kehlet, Henrik
    Kramer, Lynn D.
    Manning, Donald C.
    McCormick, Cynthia
    McDermott, Michael P.
    McQuay, Henry J.
    Patel, Sanjay
    Porter, Linda
    Quessy, Steve
    Rappaport, Bob A.
    Rauschkolb, Christine
    Revickl, Dennis A.
    Rothman, Margaret
    Schmader, Kenneth E.
    Stacey, Brett R.
    Stauffer, Joseph W.
    Von Stein, Thorsten
    White, Richard E.
    Witter, James
    Zavislc, Stojan
    [J]. JOURNAL OF PAIN, 2008, 9 (02) : 105 - 121
  • [8] A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
    Elmunzer, B. Joseph
    Scheiman, James M.
    Lehman, Glen A.
    Chak, Amitabh
    Mosler, Patrick
    Higgins, Peter D. R.
    Hayward, Rodney A.
    Romagnuolo, Joseph
    Elta, Grace H.
    Sherman, Stuart
    Waljee, Akbar K.
    Repaka, Aparna
    Atkinson, Matthew R.
    Cote, Gregory A.
    Kwon, Richard S.
    McHenry, Lee
    Piraka, Cyrus R.
    Wamsteker, Erik J.
    Watkins, James L.
    Korsnes, Sheryl J.
    Schmidt, Suzette E.
    Turner, Sarah M.
    Nicholson, Sylvia
    Fogel, Evan L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15) : 1414 - 1422
  • [9] Visceral pain - peripheral sensitisation
    Gebhart, GF
    [J]. GUT, 2000, 47 : 54 - 55
  • [10] Myofascial and visceral pain syndromes: Visceral-somatic pain representations
    Gerwin, RD
    [J]. JOURNAL OF MUSCULOSKELETAL PAIN, 2002, 10 (1-2): : 165 - 175